Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients-Reference-Cited by-同舟云学术

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients

Published:2020-02-11 Issue:5 Volume:172 Page:306
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Aldoss Ibrahim¹,La Rosa Corinna²,Baden Lindsey R.³,Longmate Jeffrey²,Ariza-Heredia Ella J.⁴,Rida Wasima N.⁵,Lingaraju Chetan Raj²,Zhou Qiao²,Martinez Joy²,Kaltcheva Teodora²,Dagis Andy²,Hardwick Nicola²,Issa Nicolas C.³,Farol Len¹,Nademanee Auayporn¹,Al Malki Monzr M.¹,Forman Stephen²,Nakamura Ryotaro¹,Diamond Don J.²,

Affiliation:

1. City of Hope Comprehensive Cancer Center, Duarte, California (I.A., L.F., A.N., M.M.A., R.N.)

2. City of Hope Comprehensive Cancer Center and the Beckman Research Institute of City of Hope, Duarte, California (C.L., J.L., C.R.L., Q.Z., J.M., T.K., A.D., N.H., S.F., D.J.D.)

3. Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts (L.R.B., N.C.I.)

4. The University of Texas MD Anderson Cancer Center, Houston, Texas (E.J.A.)

5. Biostatistics Consultant, Arlington, Virginia (W.N.R.)

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data;eClinicalMedicine;2024-08

2. Therapeutic vaccines for herpesviruses;Journal of Clinical Investigation;2024-05-01

3. Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus;Frontiers in Immunology;2024-04-03

4. Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine;npj Vaccines;2024-04-01

5. Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform;npj Vaccines;2024-03-30